163 related articles for article (PubMed ID: 32096867)
1. [Cardiac troponins - biomarkers for cardiovascular disease in chronic obstructive pulmonary disease].
Michelini Truedsson M; Stagmo M; Alm Hirsch I; Malm J; Marko-Varga G; Piitulainen E
Lakartidningen; 2020 Feb; 117():. PubMed ID: 32096867
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic and Therapeutic Implications of Elevated Plasma Troponin in Acute Exacerbated Chronic Obstructive Pulmonary Disease].
Pizarro C; Jansen F; Werner N; Nickenig G; Skowasch D
Pneumologie; 2016 Jun; 70(6):391-6. PubMed ID: 27177167
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients.
Neukamm A; Einvik G; Didrik Høiseth A; Søyseth V; Henrik Holmedahl N; Kononova N; Omland T
BMC Pulm Med; 2016 Nov; 16(1):164. PubMed ID: 27887619
[TBL] [Abstract][Full Text] [Related]
4. Elevation of cardiac troponins in exacerbation of chronic obstructive pulmonary disease.
Harvey MG; Hancox RJ
Emerg Med Australas; 2004 Jun; 16(3):212-5. PubMed ID: 15228464
[TBL] [Abstract][Full Text] [Related]
5. Coexisting chronic obstructive pulmonary disease and cardiovascular disease in clinical practice: a diagnostic and therapeutic challenge.
Leong P; Macdonald MI; Ko BS; Bardin PG
Med J Aust; 2019 May; 210(9):417-423. PubMed ID: 30907000
[TBL] [Abstract][Full Text] [Related]
6. A Study of Cardiac Troponin T Levels in Acute Exacerbation of Copd and its Correlation with Severity.
Majumder D; Manjunath M; Jayprakash S; Ishan R; Banerjee S; Kasana R
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443456
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cardiac-specific troponins in chronic obstructive pulmonary disease exacerbations: a systematic review.
Chaudary N; Geraci SA
J Miss State Med Assoc; 2014 Feb; 55(2):40-4. PubMed ID: 25771612
[TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis.
Pavasini R; d'Ascenzo F; Campo G; Biscaglia S; Ferri A; Contoli M; Papi A; Ceconi C; Ferrari R
Int J Cardiol; 2015 Jul; 191():187-93. PubMed ID: 25965630
[TBL] [Abstract][Full Text] [Related]
9. Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease.
Almagro P; Boixeda R; Diez-Manglano J; Gómez-Antúnez M; López-García F; Recio J
Int J Chron Obstruct Pulmon Dis; 2020; 15():755-764. PubMed ID: 32341642
[TBL] [Abstract][Full Text] [Related]
10. [Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics].
Ambatiello LG; Chazova IE
Ter Arkh; 2020 Apr; 92(3):78-83. PubMed ID: 32598797
[TBL] [Abstract][Full Text] [Related]
11. [Retrospective study on the prevalence of cardiovascular comorbidities in 4960 inpatients with chronic obstructive pulmonary disease in Beijing].
Wei ZM; Cai JF; Cui H; Liu AM; Li Y; Gao F; Fan L
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Mar; 32(3):297-301. PubMed ID: 21457669
[TBL] [Abstract][Full Text] [Related]
12. Physical activity, exercise and cardiac troponins: Clinical implications.
Aakre KM; Omland T
Prog Cardiovasc Dis; 2019; 62(2):108-115. PubMed ID: 30797799
[TBL] [Abstract][Full Text] [Related]
13. Cardiac dysfunction in exacerbations of chronic obstructive pulmonary disease is often not detected by electrocardiogram and chest radiographs.
Shafuddin E; Chang CL; Cooray M; McAnulty KA; Karalus NC; Lee MHS; Hancox RJ
Intern Med J; 2019 Jun; 49(6):761-769. PubMed ID: 30324703
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Biomarkers in the Identification of Future Risk in Chronic Obstructive Pulmonary Disease.
Jahn K; Papakonstantinou E; Stolz D
Curr Top Med Chem; 2016; 16(14):1539-49. PubMed ID: 26420369
[TBL] [Abstract][Full Text] [Related]
15. CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease.
Ooi H; Chen LH; Ni YL; Shen HT; Lee YH; Chu YC; Fang KC; Chen IH; Hsu SL; Chen HC; Huang CH; Fan KS; Lai CL; Hang LW
Clin Respir J; 2018 Mar; 12(3):1038-1045. PubMed ID: 28268258
[TBL] [Abstract][Full Text] [Related]
16. GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
Martinez CH; Freeman CM; Nelson JD; Murray S; Wang X; Budoff MJ; Dransfield MT; Hokanson JE; Kazerooni EA; Kinney GL; Regan EA; Wells JM; Martinez FJ; Han MK; Curtis JL;
Respir Res; 2017 Feb; 18(1):42. PubMed ID: 28245821
[TBL] [Abstract][Full Text] [Related]
17. The Importance of Measuring Troponin in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review.
Elmenawi KA; Anil V; Gosal H; Kaur H; Chakwop Ngassa H; Mohammed L
Cureus; 2021 Aug; 13(8):e17451. PubMed ID: 34603857
[TBL] [Abstract][Full Text] [Related]
18. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T.
Søyseth V; Bhatnagar R; Holmedahl NH; Neukamm A; Høiseth AD; Hagve TA; Einvik G; Omland T
Heart; 2013 Jan; 99(2):122-6. PubMed ID: 23024006
[TBL] [Abstract][Full Text] [Related]
19. Advances in understanding of mechanisms related to increased cardiovascular risk in COPD.
Rogliani P; Ritondo BL; Laitano R; Chetta A; Calzetta L
Expert Rev Respir Med; 2021 Jan; 15(1):59-70. PubMed ID: 33084434
[TBL] [Abstract][Full Text] [Related]
20. The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions.
Kallis C; Kaura A; Samuel NA; Mulla A; Glampson B; O'Gallagher K; Davies J; Papadimitriou D; Woods KJ; Shah AD; Williams B; Asselbergs FW; Mayer EK; Lee RW; Herbert C; Grant SW; Curzen N; Squire IB; Johnson T; Shah AM; Perera D; Kharbanda RK; Patel RS; Channon KM; Mayet J; Quint JK
Int J Chron Obstruct Pulmon Dis; 2023; 18():2405-2416. PubMed ID: 37955026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
